Investors

Teligent is a specialty generic pharmaceutical company (NASDAQ: TLGT). Our mission is to be a leading player in the specialty generic prescription drug market.

We sell a portfolio of prescription topical medicines and a growing number of hospital-based sterile injectable products, including cephalosporins.

Recent News

Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders

Scheduled to Reconvene on July 21, 2021 Company Urgently Encourages Stockholders to Vote BUENA, N.J. , June 30, 2021 (GL...

Learn More

Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders

Scheduled to Reconvene on June 30, 2021 Company Urgently Encourages Stockholders to Vote BUENA, N.J. , June 18, 2021 (GL...

Learn More

Teligent, Inc. Announces First Quarter 2021 Earnings Report and Provides Business Update

– Continued Remediation Progress Being Made – Reiterating Prior Guidance of Informing FDA on Inspection Readiness During...

Learn More

Investor Overview

There are no items to display.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.